Podcasts about cdces

We've got a funny, informative, helpful and no holds barred “Ask Me Anything” panels. Recorded at Moms' Night Out in Cleveland, you'll hear from two incredible experts who've lived with type 1 diabetes for decades—Julia Blanchette, PhD, RN, CDCES, and Natalie Bellini, DNP, FNP-BC, CDCES. We tackle everything from helping grandparents understand modern T1D care, to balancing diabetes in a marriage, to managing ADHD alongside diabetes in teens. We'll also dig into why screening for type 1 is so important—and how to find the community and resources that make life with diabetes just a little bit easier. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us for a Back to School webinar - sign up here Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

Think you just need more motivation or willpower to change your eating habits? Or that if you're not perfect right away, you've failed?These common beliefs might be exactly what's keeping you stuck.In this episode, I'm joined by registered dietitian and behavior change expert Laura Koller to bust 5 of the biggest myths about changing your eating habits. We'll break down why these beliefs don't work, what actually drives lasting change, and how to approach your eating habits with strategies that stick (even when motivation runs out).If you've been “doing all the right things” but still can't seem to make progress, this is the truth-bomb episode you didn't know you needed.You can find Laura Koller MS, MSEd, RD, LDN, CDCES at https://TransformRD.com______________________

Join Dr. Eric Balcavage as he explores the critical relationship between gut health and thyroid function with registered dietitian and microbiome expert Kara Siedman. This episode dives deep into how your microbiome - the collection of bacteria, fungi, and viruses living in your gut - directly impacts thyroid physiology and overall health.   Kara breaks down the complex science into actionable insights, explaining how gut dysbiosis can trigger thyroid dysfunction through inflammatory pathways, intestinal permeability, and disrupted hormone conversion. You'll discover why digestive symptoms aren't always present even when gut dysfunction is driving thyroid issues, and learn practical strategies for supporting your microbiome through diet, lifestyle, and targeted interventions.   Key topics include: The role of short-chain fatty acids, The truth about probiotic supplementation How to evaluate microbiome health The connection between GLP-1 production and metabolic function. Whether you're dealing with Hashimoto's, hypothyroidism, or other chronic conditions, this episode provides the foundational knowledge you need to understand why gut health is often the missing piece in thyroid recovery. Kara Siedman, RDN, CDCES is a registered dietitian and certified diabetes care and education specialist with over 15 years of clinical experience in inpatient care, outpatient program development, and integrative/functional nutrition. She earned her degree from the University of Massachusetts Amherst and completed her dietetic internship at Cal Poly San Luis Obispo. Kara's work in a leading gastroenterology practice sparked her transition into functional nutrition, where she integrated root-cause approaches into GI care and became a mentor and key opinion leader in the field. Her passion for the gut microbiome evolved into a professional specialty, leading her to collaborate with biotech and microbiome-focused companies like Pendulum, Microbiome Labs, and now Resbiotic. As Director of Partnerships at resbiotic, Kara educates healthcare providers on microbiome science and the clinical application of targeted microbiome therapies. Known for her ability to simplify complex research, she brings clarity, credibility, and passion to gut health education. https://resbiotic.com/

Conversation #340:  The Story, Journey and Passion of Michelle Routhenstein, MS, RD, CDCES, CDN, Owner and President of Entirely NourishedToday's conversation is with Michelle Routhenstein, a registered dietitian, Owner and President of Entirely Nourished, a virtual Nutrition counseling and consulting private practice. She merges lifestyle, medical history, and goals with science based research to achieve long term results. As a cardiology dietitian and certified diabetes educator, she provides personalized science based nutrition to help her clients prevent chronic disease. Michelle shares some great insight for dietitians and how they can have a seat at the table.  Please enjoy my conversation with Michelle.Connect with Michelle:Entirely Nourished WebsiteInstagram, LinkedInwww.anneelizabethrd.comCopyright © 2025 AEHC & OPISong: One Of These DaysArtist: The Geminiwww.thegeminimusic.comMusic used by permission. All rights received.© ASCAP OrtmanMusic

Becky Sulik, RDN, LD, CDCES, and Bethany Long, BSN, RN, CDCES, join us to discuss how automated insulin delivery systems (AID), like the Omnipod 5, are transforming diabetes management and making mealtime bolusing easier. Becky and Bethany share insights on the Omnipod 5 AID system, including user-friendly built-in features that facilitate onboarding and increase carb awareness skills in a variety of people with diabetes. The episode highlights real-world applications and personal stories that diabetes care and education specialists can utilize in practice to quickly onboard and empower their clients today.  This episode was supported by Insulet. A guest featured on this show has a commercial relationship with Insulet, and another guest is an employee of the company. The opinions expressed in this webinar are those of the speakers and do not reflect the views or positions of Insulet.Resources: Omnipod resources for healthcare professionals: www.omnipod.com/hcp  Omnipod 5 Custom Foods blog post: www.omnipod.com/hcp/blog/tips-guidelines/custom-foods  Omnipod 5 Custom Foods brochure: www.omnipod.com/sites/default/files/omnipod-5_hcp_custom-foods-guide_us-english.pdf  Omnipod 5 simulator app for iOS: apps.apple.com/us/app/omnipod-5-simulator/id1552469689  Omnipod 5 simulator app on Google Play: play.google.com/store/apps/details?id=com.insulet.simulator&hl=en_US&gl=US&pli=1  References: Davis GM, et al. Simplified Meal Bolus Strategies for the Omnipod®5 Automated Insulin Delivery (AID) System in People with Type 2 Diabetes (T2D): Sub-Analysis of the SECURE-T2D Study. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. Post-hoc analysis limits conclusions. Insulet Data on file. RF-062025-00012Important safety information: The Omnipod® 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin and type 2 diabetes in persons aged 18 and older. Rx only.  WARNING: Do not use SmartAdjust™ technology for people under the age of 2 or who require less than 5 U of insulin per day. Visit omnipod.com/safety for complete safety information. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Leadership isn't just about guiding others—it starts with leading yourself. In this lively and insightful conversation, Beth Chapman Kaufmann and Nicole Santonastaso share how getting clear on who you are, what you do best, and where you're headed can transform the way you lead.With plenty of laughs, relatable stories, and practical takeaways, Beth and Nicole dive into CliftonStrengths, True North Statements, and why reflection time is the secret ingredient for intentional leadership. Whether you're leading a team, your family, or just yourself, this episode will inspire you to embrace your strengths and confidently chart your own course.

Send us a message!Laura Koller, MS, MSEd, RD, LDN, CDCES, is a Registered Dietitian with over 20 years of clinical experience, including two decades as a dialysis dietitian. Before pursuing a career in nutrition, she taught junior high English, a role that sparked her passion for education and has shaped her approach to teaching and behavior change. As the founder of Transform RD, Laura combines her expertise in nutrition, education, and behavior change strategies to help dietitians simplify client change. She also hosts the Dietitian Book Club, where dietitians explore fresh and insightful books for professional growth. Laura is passionate about making behavior change easier for both clients and practitioners, and she loves helping people move from feeling stuck and frustrated to feeling capable and confident in their ability to achieve lasting success. Learn more at https://www.transformrd.com/ or email her at laura@transformrd.com

On this episode of the Huddle, Kelly Postiglione Cook, RN, MSN, ANP-BC, CDCES, BC-ADM, and Sean Oser, MD, MPH, CDCES have a conversation about the importance of utilizing automated insulin delivery systems, like the iLet bionic pancreas, more widely in primary care. They provide insight into a study that evaluated the success of implementing use of the iLet bionic pancreas in a primary care setting, how the results illustrated that this technology can be more widely utilized in these settings, and the role diabetes care and education specialists can play in this work.This episode is sponsored by Beta Bionics. Episode References: Bionic Pancreas Research Group. Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 2022;387:1161-1172 DOI: 10.1056/NEJMoa2205225 Russell SJ, Selagamsetty R, Damiano E. Real-world efficacy of the iLet bionic pancreas in adults and children during the first eighteen months of commercial availability. Presented at the American Diabetes Association 85th Scientific Sessions, June 20-23, 2025, Chicago, IL.   Oser SM, Putman MS, Russel SJ, et al. Assessing the iLet Bionic Pancreas deployed in primary care and via telehealth: a randomized clinical trial. Clin Diabetes 2025; cd240104. https://doi.org/10.2337/cd24-0104 Oser C, Parascando JA, Kostiuk M, et al. Experiences of people with type 1 diabetes using the iLet bionic pancreas in primary care: A qualitative analysis. Clin Diabetes 2024 https://doi.org/10.2337/cd24-0060.  Sulik B, Postiglione Cook K, MacLeod J. Meals no longer need to be math problems: Shifting from precise carbohydrate counting to a continuum of carbohydrate awareness as automated insulin delivery advances. Diabetes Technology and Obesity Medicine 2025;1(1):79-83. DOI: 10.1089/dtom.2025.0010.  Resources:Learn more about Beta Bionics here: https://www.betabionics.com/Explore the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about a two-part course on integrating diabetes technology into primary care, put on through the collaboration of AANP and ADCES:Part 1: Integrating Diabetes Technology into Primary Care Part 1: Overview and Clinical ScenariosPart 2: Integrating Diabetes Technology into Primary Care Part 2: Interactive Case StudiesDive deeper into how diabetes technology can be incorporated into primary care on another recent episode of The Huddle featuring Kathryn Evans Kreider DNP, FNP-BC, BC-ADM, FAANP: https://thehuddle.simplecast.com/episodes/embracing-diabetes-technology-in-primary-care Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Even for those not on insulin, Continuous Glucose Monitoring (CGM) is transforming the way HCPs approach diabetes treatment. Cher Pastore, MS, RD, CDCES, BC-ADM and guest David Doriguzzi, a Physician Assistant in endocrinology and internal medicine explore how Dexcom G7 and Stelo are reshaping diabetes management for people with type 1 diabetes, type 2 diabetes, and prediabetes. Together, they break down how Dexcom's portfolio provides real-time glucose monitoring, reveals patterns invisible through traditional blood sugar monitoring, and inspire meaningful behavior change. David shares patient stories that demonstrate how CGM is helping individuals recognize how food, activity and medications impact their diabetes management. He also explains how CGM empowers providers to tailor diabetes education and medication strategies, especially in primary care settings with limited access to endocrinologists.  Whether you're managing type 1 diabetes, type 2 diabetes or on the journey to prevent it, this conversation showcases how diabetes technology like CGM can simplify treatment decisions, personalize care, and ultimately make an impact for both patients and providers.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Public health and clinical practice are closely connected. Guest Erin Ferranti, PhD, MPH, RN, CDCES,FAHA, FPCNA, about the importance of public health for all patients, and how to get more involved.Resources:PCNA Advocacy Resources: https://pcna.net/news/pcna-advocacy-paving-the-way-for-cardiovascular-health-through-policy-action/ Life's Essential 8 (TM): https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8 Association of Public Health Nurses: https://www.phnurse.org/ American Public Health Association: https://www.apha.org/ Health Resources & Services Administration: https://www.hrsa.gov/ National Institutes of Health: https://www.nih.gov/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong? Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD Music by Good Talk

Ashley and Sam welcome Janice Dada, CEDRD, CDCES, and Certified Intuitive Eating Counselor, to discuss diabetes care through a non-weight-focused lens. In this episode, Janice shares insights from her new book, Intuitive Eating for Diabetes: The No Shame, No Blame, Non-Diet Approach to Managing Your Blood Sugar, where she integrates the 10 principles of Intuitive Eating by Evelyn Tribole and Elyse Resch with her own “four pillars” approach. This conversation is valuable for anyone who has ever been told to lose weight to improve a health symptom—and is looking for a more compassionate, evidence-based alternative. To learn more, connect with Janice at https://www.socalnw.com, and find her book wherever books are sold.   If you enjoy our show, please rate, review, subscribe, and tell your friends and colleagues!   Interested in being a guest on All Bodies. All Foods.? Email podcast@renfrewcenter.com for a chance to be featured.   All Bodies. All Foods. is a podcast by The Renfrew Center. Visit us at: https://renfrewcenter.com/

On the latest episode of The Huddle, we're joined by Jay Shubrook, DO, BC-ADM, FACOFP, FAAFP, Anne Lee, MEd, RDN, CDCES, and Clipper Young, PharmD, MPH, as they talk about Touro University' unique Mobile Diabetes Education Center (MOBEC). They explain how the center was formed, the services MOBEC provides, and how others can replicate this work to serve and educate a greater population of people with and at risk for diabetes.Learn more about MOBEC here: Touro University Californiahttps://diabetesjournals.org/clinical/article/42/1/125/153645/Community-Based-Diabetes-Awareness-Strategy-With  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Eating well with diabetes doesn't have to feel like a burden. In this episode, Lizzy Katz, RD, CDCES, Diabetes Program Coordinator at UM Capital Region Health shares how to make smart food choices, hear realistic tips on dining out and learn how to build a nutrition plan that not only supports glucose control but fits your values, your family, and your life.

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

Gretchen Zimmermann, MBA, RD, LDN, CDCES, CSOWM is a healthcare executive, registered dietitian, and thought leader in digital health innovation. With over 15 years of experience in clinical care and leadership, she is committed to transforming healthcare through cost-effective, outcome-driven, and patient-centered care models. Her expertise is nationally recognized, with publications in academic and industry journals on diabetes, digital health, and nutrition... and today she joins me to talk all things GLP-1. Let's get all the facts, shall we? Connect with Gretchen: https://www.instagram.com/gretchenzimmermann.rd/  https://www.vida.com/  ---  ❤️ INSTAGRAM: www.instagram.com/KindalBoyleFitness/ 

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, recorded during the 85th Scientific Sessions of the American Diabetes Association (ADA 2025) in Chicago, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with Rachael Sood, RN, MSN, APRN, NP, CDCES, founder of The Diabetes Collective, about modern approaches to diabetes care, patient engagement, and the role of social media in education and advocacy. The discussion highlights Sood's innovative use of social media to make diabetes education accessible and engaging. Known for creative and widely shared content—such as her wedding-themed video announcing the Dexcom G7 and Omnipod 5 integration—Sood shares how spontaneous, relatable messaging can improve awareness and patient connection. Her content spans emerging therapeutics like GLP-1 receptor agonists, type 1 diabetes staging and screening, and technology updates such as ketone monitoring and CGM integration. Sood reflects on the emotional impact of recent ADA presentations, including advances in islet cell therapy and the evolving treatment landscape for both type 1 and type 2 diabetes. She emphasizes the importance of healthcare providers offering clear, empathetic, and tailored care, recounting a patient case where basic interventions—CGM use, education, and therapeutic escalation—had a transformative effect after years of clinical inertia. The episode underscores the value of clinician-led care, continuity, and communication, particularly in independent practices. Sood also points to the importance of collaborative energy within the diabetes community, noting the power of partnerships among healthcare professionals, patients, and advocacy groups to drive progress. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Sanofi, and others. Sood has no relevant disclosures to report.

A series of conversations with Jordan Wagner, CDCES. In this episode, diabetes management in the hospital.  Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

More About Diana:Click here to visit Diana's websiteClick here to follow Diana on instagram- - - - - - -More About Eleni:Join the Body Kind Nutrition community and recipe program as a free or paid member:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to sign up and join our Body Kind Nutrition community on patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Eleni Agresta Levine MS RDN is a weight-inclusive registered dietitian who helps women heal their relationship with food and their bodies. She works with clients virtually and is a Health at Every Size (HAES®) aligned healthcare provider.⁠⁠⁠⁠⁠⁠⁠⁠⁠Eleni's Instagram: @all.bodies.nutrition⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Interested in working with Eleni? Click here to apply⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email Eleni at: All.Bodies.Nutrition@gmail.com

In this episode of SHE MD, hosts Mary Alice Haney & Dr. Thais Aliabadi welcome Wendy Lopez, MS, RD, CDCES & Jessica Jones, MS, RD, CDCES, registered dietitian nutritionists and certified diabetes care specialists. They discuss their telehealth platform, Diabetes Digital, designed to help women manage and prevent diabetes through virtual nutrition counseling. The conversation covers various aspects of diabetes, including its types, risk factors, and management strategies.Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii. Sponsors: Ollie: Visit https://ollie.com/SHEMD today for 60% off your first box ofmeals! #ToKnowThemIsToLoveThemSleepMe: Visit www.sleep.me/SHEMD to get your Chilipad at 20% off with code SHEMDOpill: Opill is birth control in your control, and you can use code SHEMD for twenty five percent off your first month of Opill at Opill.comStrivektin: Discover the Science Behind Great SkiniRestore: Reverse hair loss with @irestorelaser and get $625 off with code shemd at https://www.irestorelaser.com/SHEMD! #irestorepodMedronic: For more information and to take the pledge to talk to your mother or a woman in your life about heart health, visit Alettertomymother.com Jessica Jones and Wendy Lopez's Key Takeaways:You don't have to wait until things are “bad enough” to get support: Preventative care is powerful. Whether you're newly diagnosed or just want to feel better in your body, it's okay to seek help now.Take a 10-minute walk after meals: Incorporate a brief walk after your largest meal to help manage blood sugar levels.Virtual care can be deeply personal and community-centered: Diabetes Digital is designed to be flexible, culturally competent, and shame-free — because healthcare should meet you where you are.Balance your meals: Ensure each meal includes carbohydrates, protein, fiber, and healthy fats for optimal blood sugar control.Incorporate strength training: Engage in strength training exercises 2-3 times a week to maintain muscle mass and improve insulin sensitivity.In This Episode: (00:00) Intro (01:19) Introducing Wendy Lopez and Jessica Jones(02:17) Origins of Food Heaven and Diabetes Digital(06:26) Food access and physical activity barriers(10:44) Differences between type 1 and 2 diabetes(23:01) Introducing carbs in a balanced way(27:15) Intermittent fasting and diabetes management(28:48) Protein and exercise with GLP1 medications(31:30) Menopause and blood sugar management(43:24) Barriers for women of color entrepreneurs(47:30) How to access Diabetes Digital servicesRESOURCES:Diabetes Digital Website: https://diabetesdigital.co/Diabetes Digital Instagram: http://www.instagram.com/diabetesdigitalco/Food Haven Podcast Facebook: https://www.facebook.com/diabetesdigitalco/Diabetes Digital Tiktok: https://www.tiktok.com/@diabetesdigital.coDiabetes Digital Podcast: https://open.spotify.com/show/2xRnLYs57KNAjIpBCrk9WNGUEST BIOGRAPHY:Wendy Lopez and Jessica Jones are nationally recognized Registered Dietitian Nutritionists and Certified Diabetes Care and Education Specialists. With over a decade of clinical experience, they have helped thousands of individuals improve their relationship with food and achieve better health outcomes. Wendy and Jessica are the co-founders of Diabetes Digital, an insurance-covered telehealth platform designed for women of diverse backgrounds to manage and prevent diabetes through 1:1 virtual nutrition counseling. Through their previous work with Food Heaven, Wendy and Jess have made a lasting impact on nutrition and wellness, promoting healthier relationships with food and inclusive health education.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of The Huddle, Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES and Debbie Hinnen, APN, BC-ADM, CDCES, FAAN discuss the importance of medication persistence, how to talk to clients about starting and staying on diabetes medications, and strategies to help clients stay consistent with their medication taking. This episode was made possible with support from Lilly, A Medicine Company.Learn more about the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about the ADCES7 Self-Care Behaviors: Self-Care Tips (ADCES7)References:Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence, 11, 1103–1117. https://doi.org/10.2147/PPA.S136639McGovern, A., Hinton, W., Calderara, S. et al. A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther 9, 229–242 (2018). https://doi.org/10.1007/s13300-017-0361-5Evans M, Engberg S, Faurby M, Fernandes JDDR, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2022; 24(3): 377-390. doi:10.1111/dom.14603Sabaté E., Adherence to Long-Term Therapies: Evidence for Action, 2003, World Health Organization, Geneva, Switzerland.https://www.ama-assn.org/delivering-care/physician-patient-relationship/8-reasons-patients-dont-take-their-medicationshttps://www.npr.org/sections/health-shots/2017/09/08/549414152/why-do-people-stop-taking-their-meds-cost-is-just-one-reasonhttps://www.adces.org/docs/default-source/handouts/adces7/handout_pwd_adces7_takingmedication.pdf?sfvrsn=4e3f6359_13 Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

The "Bros" host a SUPER SIZED two-hour episode discussing the importance of nutrition with registered dietitian and owner of Racer's Edge Nutrition Nicole Rubenstein, MS, RDN, CSSD, CDCES, world renowned spine surgeon, Ironman and offshore racing's Medical Director Dr. Michael Janssen and world champion offshore racer, Iconic Marine Group's Vice President of Product Development and President of the newly formed World Powerboat Racing Association Jeff Harris. The esteemed panel of guests explain how crucial it is to fuel the body properly and continuously, sometimes even more so than the boats that they race–for optimum performance and peak results. They also discuss the new WPRA and what it's all about.  Don't miss this extra large episode! Myrick Coil is the driver for the National Champion Monster Energy / M CON Class 1 team, Speedboat Magazine Test Team Driver, lead shop foreman at Performance Boat Center and a dedicated family man.  Ray Lee is the publisher of the national/international publication Speedboat Magazine, where nine high quality issues are printed each year with global distribution, and popular social media platforms on Facebook, Instagram and TikTok.  With all of the "Bros" experience, knowledge, and friends and colleagues in the industry and sport, this podcast is sure to entertain, enthuse and educate the powerboating community. 

Creatine is often associated with athletic performance, but growing evidence points to its broader benefits for brain health, aging, and overall muscle preservation. This episode breaks down what pharmacists need to know about creatine's evidence-based uses, safety considerations, and counseling opportunities. Tune in to strengthen your knowledge and help ensure patients receive accurate, evidence-based information about this widely used supplement.  HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMark Smith, PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood,  PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial HospitalPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the evidence-based uses of creatine beyond athletic performance, including its potential benefits for brain health and aging.2. Identify key counseling points for pharmacists when discussing creatine supplementation with patients.0.05 CEU/0.5 HrUAN: 0107-0000-25-200-H01-PInitial release date: 6/9/2025Expiration date: 6/9/2026Additional CPE details can be found here.

Creatine is often associated with athletic performance, but growing evidence points to its broader benefits for brain health, aging, and overall muscle preservation. This episode breaks down what pharmacists need to know about creatine's evidence-based uses, safety considerations, and counseling opportunities. Tune in to strengthen your knowledge and help ensure patients receive accurate, evidence-based information about this widely used supplement. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMark Smith, PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood,  PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial Hospital Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the evidence-based uses of creatine beyond athletic performance, including its potential benefits for brain health and aging.2. Identify key counseling points for pharmacists when discussing creatine supplementation with patients.0.05 CEU/0.5 HrUAN: 0107-0000-25-200-H01-PInitial release date: 6/9/2025Expiration date: 6/9/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Pregnant Patients are Empowered by Real-Time Continuous Glucose Monitoring (CGM): How Biosensor Technology Supports Type 1 Diabetes, Type 2 Diabetes, Prediabetes, and Gestational Diabetes How does real-time data from Continuous Glucose Monitoring (CGM) reshape how we talk about food, exercise, and metabolic health Exploring how CGM - and tools like Dexcom and Stelo are empowering people with type 1 diabetes, type 2 diabetes, and even prediabetes to better understand their glucose patterns and take charge of their diabetes management is host Cher Pastore, MS, RD, CDCES, BC-ADM, joined by Rachel Stahl Salzman, a registered dietitian and certified diabetes education specialist at Weill Cornell.  Rachel shares practical insights from her work in diabetes treatment, including with pregnant patients managing gestational diabetes. She also discusses her recent study presented at Advanced Technologies & Treatments for Diabetes (ATTD), where CGM use helped women with gestational diabetes feel more confident and in control of their care.  From glucose tracking to blood sugar monitoring, this episode explores how biosensor technology supports more personalized, effective diabetes management - not just for patients, but for endocrinologists and primary care providers too. Whether you're focused on diabetes treatment, nutrition, or simply curious about the future of diabetes technology, this episode of Real-Time Real Talk reveals how CGM is making care more precise, proactive, and powerful. Brought to you by Dexcom https://provider.dexcom.com/education-research/podcast

In this eye-opening episode of The Period Whisperer, I sit down with Wendy Lopez, MS, RDN, CDCES, a leading Registered Dietitian and the co-founder of Food Heaven, to tackle a topic that impacts so many women in perimenopause: blood sugar and insulin resistance. Wendy is passionate about making nutrition accessible, and in this conversation, we dive deep into how hormonal shifts during perimenopause can affect blood sugar and insulin sensitivity.What you will learn:

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina's expertise, dedication, and care improved her health and changed her life for the better.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Dietitian Boss podcast, host Libby Rothchild welcomes Jessica Jones, CEO and Co-founder of Diabetes Digital, a telehealth platform specializing in virtual nutrition counseling. Jessica shares her inspiring journey from starting the Food Heaven media company to leading a team of dietitians at Diabetes Digital. She discusses the importance of niching down, the impact of aligning with core values, and the intricacies of working with insurance to offer accessible care. Jessica also offers practical advice for dietitians interested in telehealth, emphasizing the significance of sales skills and robust referral networks. 00:00 Welcome to Dietitian Boss 00:37 Introducing Jessica Jones 02:11 Jessica's Journey from Content Creation to Telehealth 03:43 Challenges and Reflections During the Pandemic 04:27 Balancing Management and Patient Care 05:51 The Importance of Outreach and Sales 09:39 Building a Strong Brand with Food Heaven 14:01 Opportunities and Challenges in Telehealth 17:14 Strategies for Increasing Profit Margins 18:08 Roles and Responsibilities of Co-Founders 20:55 Tips for Dietitians Entering Telehealth 23:00 Final Thoughts and Resources Bio: Jessica Jones, MS, RDN, CDCES, is a nationally recognized dietitian and diabetes educator. As CEO and co-founder of Diabetes Digital, she leads an insurance-covered telehealth platform offering culturally inclusive nutrition counseling for diabetes and prediabetes. She co-hosts the Diabetes Digital Podcast and co-founded Food Heaven, a platform with over 250K followers and 5M podcast downloads. Jessica co-authored 28-Day Plant-Powered Health Reboot and A Diabetes Guide to Enjoying the Foods of the World and wrote the Diabetes chapter of the Food and Nutrition Care Manual. Her work has appeared in Oprah Magazine, SELF, and Bon Appétit. She lives in Sacramento with her husband and puppy. Connect with Libby: Instagram: @libbyrothschild | @dietitianboss YouTube: Dietitian Boss Connect with Jessica Jones Diabetes Digital Website (for signing up for an appointment): diabetesdigital.co Diabetes Digital Facebook: https://www.facebook.com/diabetesdigitalco/ Diabetes Digital Instagram: @diabetesdigitalco Diabetes Digital YouTube: @diabetesdigitalco Diabetes Digital TikTok: @diabetesdigital.co Diabetes Digital LinkedIn: https://www.linkedin.com/company/98759072 Diabetes Digital Podcast: open.spotify.com/show/2xRnLYs57KNAjIpBCrk9WN Resources: Discover the seamless experience of Practice Better through our referral link! Join us on a journey of enhanced wellness and efficiency. Start here! Join our membership The Library HERE

This week on The Huddle, we're resharing an episode from last summer featuring Kristine Batty, PHD, APRN, BC-ADM, CDCES, FADCES as she discusses her experience both living with Type 1 diabetes and working with people with diabetes as a certified diabetes care and education specialist. She shares the importance of putting yourself in your client's shoes in order to understand their goals and pain points and support their needs, especially when it comes to diabetes technology.Visit danatech here: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about the latest developments in T1D screening here: T1D ScreeningView Kristine's video series below:https://www.youtube.com/watch?v=HPqraDx-aQwhttps://www.youtube.com/watch?v=SBYpv3LuzBwhttps://www.youtube.com/watch?v=otRUIrx6FkIhttps://www.youtube.com/watch?v=uDrDSSK99-A Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

In our latest DNS podcast episode, we chat with Egondu Onuoha, MS, RD, CDN, IBCLC, RLC, CDCES, GPC, FAND, FILCA —healthcare executive and former Academy board member—about how AI is transforming nutrition assessments, predictive analytics, and personalized care plans.Join us as we explore how AI is enhancing the accuracy and efficiency of nutrition assessments, the most promising tools available to clinicians, and the potential of predictive analytics to identify patients at risk of malnutrition. We'll also tackle challenges like implementation, ethical considerations, and maintaining evidence-based care in an AI-driven world. This episode is hosted by Christina Rollins, MBA, MS, RDN, LDN, FAND, CNSC and was recorded on 4/14/25.

In this episode of the Active Bariatric Nutrition Podcast, I interviewed Registered Dietitian, Tracy Bento, also known as @balancedbitesnutrition on IG. We discussed:Common symptoms women experience in perimenopauseWhat contributes to weight gain during perimenopause/menopauseWhat are the biggest nutrition recommendations Tracy providesVitamin and mineral supplements that may be helpful during this transitionThe one thing Tracy wishes she had known as she went through perimenopauseWhere to follow or work with Tracy Bento, RD, CDCES, CSOWM, MSCPInstagram: @balancedbitesnutritionWebsite: Balanced Bites NutritionThe Menopause SocietyLet me know what you thought of the episode!To learn more about my new program, Bariatric STRONG which will open again in Fall, 2025, click HERE to join the waitlist as space is limited and will fill up fast! To learn more about my Bariatric Nutrition Coaching Programs, go to: www.activebariatricnutrition.comFollow Active Bariatric Nutrition at:Instagram - @activebariatricFacebook - Active Bariatric NutritionYouTube - Active Bariatric NutritionTikTok - ActiveBariatricNutrition

How can Continuous Glucose Monitoring (CGM) help people with type 2 diabetes feel more empowered and in control of their health? Exploring compelling new research presented at the Advanced Technologies & Treatments for Diabetes (ATTD) conference is host Cher Pastore, MS, RD, CDCES, BC-ADM, and guest Sim Singh, Senior Director of Behavioral and Translational Science at Dexcom. Together, they unpack findings from a 30-day study of Dexcom G7 use in people with type 2 diabetes, including those not on insulin. The results show significant improvements in glucose tracking, behavioral shifts like better nutrition and increased physical activity, and enhanced metabolic health and confidence - especially among CGM-naive users. Sim also shares insights from a Canadian trial and discusses how CGM is transforming diabetes education, not only for patients but for endocrinologists and primary care providers as well. Whether it's supporting blood sugar monitoring, enabling personalized diabetes treatment, or simply helping people better understand their glucose patterns, this conversation highlights how CGM and biosensor technology are reshaping diabetes management - for people with type 1 diabetes, type 2 diabetes, and even prediabetes.

Registration is open now for ADCES25 taking place August 8-11 in Phoenix, AZ! Our conference planning chair Christina Whitehouse, RN, MSN, APRN, ARNP, FADCES, CDCES, shares what to look forward to at this year's conference, and why ADCES' annual conference is the place to be for all diabetes care and education specialists and other professionals in the diabetes space. Register for this year's annual conference at ADCES 2025 Annual MeetingExplore all there is to see in Phoenix at Roosevelt Row Arts District | Downtown Phoenix Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

Nicole DeMasi Malcher, MS, RD, CDCES delves into the connection between ADHD and disordered eating. Learn why traditional diets often fail — and why intuitive eating may work — and come away with practical strategies for ADHD-friendly eating habits. ADHD and Nutrition: Additional Resources Free Download: Health & Fitness — Lifestyle Changes for Adults with ADHD Self-Test: Eating Disorders in Adults Read: 40 Ways to Eat Healthy and Resist Impulsive Snacking Read: Healthy Eating Habits for Impulsive, Dopamine-Starved ADHD Brains Read: Build a Better Relationship with Food to Benefit Your Brain Access the video and slides for podcast episode #549 here: https://www.additudemag.com/webinar/adhd-and-eating-habits/ This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/additude and get on your way to being your best self. Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss pharmacists' role in counseling patients on GLP-1s as well as the common trends, challenges, and successes she's seen among her patient population. 

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We'll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.Special Guests:Lauren G. Pamulapati, PharmD, BCACPAssociate Professor, Ambulatory CareVirginia Commonwealth University School of PharmacyClinical Pharmacist, Hayes Willis Health Center/VCU HealthChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy PracticeDirector, PGY2 Ambulatory Care Residency ProgramMidwestern University College of Pharmacy, Downers Grove CampusClinical Pharmacist, Northwestern MedicineTRC Editorial Advisory Board Participant:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleFor the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Diabetes Medications: Cardiovascular and Kidney ImpactChart: Drugs for Type 2 Diabetes Algorithm: Stepwise Treatment of Type 2 DiabetesChart: Comparison of GLP-1 AgonistsToolbox: Improving Heart Failure CareSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Hormone replacement therapy (HRT) remains a cornerstone of managing menopausal symptoms, but understanding the latest evidence is crucial for safe and effective use. This episode dives into evidence-based therapies, weighing benefits and risks and highlighting the pharmacist's role in guiding personalized care. Tune in to stay updated on the science behind HRT and its evolving role in patient care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTAshley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCPClinical ProfessorPurdue UniversityPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the latest evidence-based approaches to hormone replacement therapy (HRT) for managing menopausal symptoms.2. Identify key considerations for pharmacists when counseling patients on the benefits, risks, and appropriate use of HRT.0.05 CEU/0.5 HrUAN: 0107-0000-25-087-H01-PInitial release date: 3/31/2025Expiration date: 3/31/2026Additional CPE details can be found here.

Hormone replacement therapy (HRT) remains a cornerstone of managing menopausal symptoms, but understanding the latest evidence is crucial for safe and effective use. This episode dives into evidence-based therapies, weighing benefits and risks and highlighting the pharmacist's role in guiding personalized care. Tune in to stay updated on the science behind HRT and its evolving role in patient care.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTAshley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCPClinical ProfessorPurdue University Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the latest evidence-based approaches to hormone replacement therapy (HRT) for managing menopausal symptoms.2. Identify key considerations for pharmacists when counseling patients on the benefits, risks, and appropriate use of HRT.0.05 CEU/0.5 HrUAN: 0107-0000-25-087-H01-PInitial release date: 3/31/2025Expiration date: 3/31/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Integrating glucose sensor Dexcom G7 with digital health apps like Happy Bob and Undermyfork is improving diabetes treatment decisions and patient engagement. Whether it's gamifying glucose tracking, uncovering personalized glucose patterns, or making real-time adjustments, these digital tools empower both patients and providers. Cher Pastore, MS, RD, CDCES, BC-ADM is joined by diabetes experts Jami Klein, BSN, RN, CDCES and Rachael Sood, RN, MSN, APRN, NP-C, CDCE to explore how apps like Happy Bob and Undermyfork integrate with Continuous Glucose Monitoring (CGM) to make tracking blood sugar levels more interactive and insightful. Rachael shares real-world experiences from her diabetes care clinic, demonstrating how CGM-driven insights help patients with Type 1 diabetes, Type 2 diabetes, and prediabetes make better-informed treatment decisions. Jami brings her personal perspective on using CGM and apps to optimize diabetes management, highlighting the role of glucose sensors, blood sugar monitoring, and biosensor technology in simplifying daily care.Together, they explore how diabetes technology is reshaping diabetes education, treatment, and metabolic health, and how digital health solutions are making a lasting impact in endocrinology and primary care. Brought to you by Dexcom https://www.dexcom.com/

Dietitian and diabetes educator Janice Dada joins us to discuss why there's so much stigma and blame on people with diabetes, the wellness-culture belief that people can “reverse diabetes” by restricting foods and taking a bunch of supplements, why people don't “give themselves diabetes” by eating too much sugar, the myth that people with diabetes can't eat sugar or carbs, her new book on intuitive eating for diabetes, and more. Behind the paywall, we get into the myths about diabetes and body size, the harms of trying to lose weight with diabetes, issues with the “prediabetes” label, the GLP-1 craze, and how to practice intuitive eating with diabetes. This episode is cross-posted from our other podcast, Rethinking Wellness. Paid subscribers can hear the extended interview, and the first half is available to all listeners. To upgrade to paid, go to rethinkingwellness.substack.com. Janice Dada is a weight-inclusive registered dietitian with a private practice in Newport Beach, CA. She is a certified intuitive eating counselor, certified diabetes care and education specialist (CDCES), and certified eating disorders specialist (CEDS). She is passionate about simplifying and destigmatizing the nutrition- and weight-based discourse around diabetes. Intuitive Eating for Diabetes: The No Shame, No Blame, Non-Diet Approach to Managing Your Blood Sugar is her first book. Check out Christy's three books, Anti-Diet, The Wellness Trap, and The Emotional Eating, Chronic Dieting, Binge Eating & Body Image Workbook for a deeper dive into the topics covered on the pod. If you're ready to break free from diet culture and make peace with food, come check out Christy's Intuitive Eating Fundamentals online course. For more critical thinking and compassionate skepticism about wellness and diet culture, check out Christy's Rethinking Wellness podcast! You can also sign up to get it in your inbox every week at rethinkingwellness.substack.com. Ask a question about diet and wellness culture, disordered-eating recovery, and the anti-diet approach for a chance to have it answered on Rethinking Wellness. You can also subscribe to the Food Psych Weekly newsletter to check out previous answers!

As dietitians, our career paths don't have to be linear. Sometimes, walking away from something highly successful is the key to finding true fulfillment.In this episode, I sit down with Jessica Jones, MS, RD, CDCES, who shares her journey of leaving a thriving media brand to build something that aligned more deeply with her purpose. Despite the massive success of Food Heaven, a wellness brand and podcast with over 5 million downloads, Jessica found herself craving something different, something more meaningful. That led her to co-found Diabetes Digital, a virtual nutrition counseling practice providing insurance-covered diabetes care.In this candid chat, we dive into:Why success doesn't always equal fulfillment, and how Jessica knew it was time to pivotThe shift from media & brand partnerships to an insurance-based group practiceThe challenges & rewards of running a telehealth businessHow niching into diabetes & prediabetes transformed her careerWhat it really takes to scale a group practice while staying profitableThis episode is a must-listen for any dietitian considering a career pivot or anyone curious about what it really looks like to build a business that aligns with your values.If this episode resonated with you, I'd love to hear about it so please rate & review it!Links:Join our FREE dietitian communityBook your FREE Business Strategy Call today (open to starting, growing or scaling dietitian business owners)Diabetes DigitalDiabetes Digital PodcastFood HeavenCareers at Diabetes DigitalFollow Diabetes Digital on Instagram: @diabetesdigitalcoTranscript Summary:[00:00:00] Welcome & Introduction & Why We're Talking About Hiring [00:02:00] Jessica's Journey: From Journalism to Dietetics [00:06:00] The Birth of Food Heaven: A Media Empire [00:10:00] Staying Consistent for Years Without Making Money [00:14:00] How Food Heaven Made Money: Revenue Streams [00:19:00] Transparency in Business: What Worked & What Didn't [00:21:00] Leaving Food Heaven & The Shift to Diabetes Digital[00:23:00] The Lightbulb Moment: Starting an Insurance-Based Practice [00:26:00] The Reality of Running an Insurance-Based Group Practice [00:32:00] The Challenges of Insurance Billing & Verification [00:36:00] Growth Plans for Diabetes Digital[00:42:00] The Power of Niching: Why Specializing in Diabetes Was Key [00:45:00] Jessica's Typical Day as a Business Owner

On this episode of The Huddle, Chris Memering, MSN, RN, CDCES, BC-ADM, talks about the value that diabetes care and education specialists bring to the inpatient care setting. She outlines the importance of continuity of care between the inpatient and outpatient setting, how DCES in inpatient help increase patient satisfaction and safety, and how others in the inpatient setting can demonstrate their value to their hospital leadership.Learn more about how to showcase the value of the diabetes care and education specialty in our value toolkit created especially for ADCES members. Log in here to view the toolkit:  Showcase Value ToolkitOr click here to become an ADCES member to access helpful resources like this one: MembershipLearn more about ADCES' inpatient certificate program focused on knowledge and skills necessary for effective inpatient diabetes care: https://www.adces.org/store/certificate-programs/detail/inpatient-certificate-program-transforming-care-and-enhancing-lives Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

In today's episode of The Root Cause Medicine Podcast, Dr. Kate Kresge sits down with Cass Nelson-Dooley and Cat Simmons from Diagnostic Solutions Laboratory to explore the clinical applications of organic acids testing. You'll hear us discuss: • How urine testing may offer different insights into metabolism compared to blood tests • How urine tests may help identify patterns related to nutrient status without invasive testing • Exploring how neurotransmitter metabolites may relate to mood and brain health • Why organic acids testing may be a useful option for children, especially when blood draws are difficult Cat Simmons, MS, RD, CDCES is a clinical dietitian with a master's degree in metabolic physiology and integrated exercise science from Colorado State University. With over 15 years of experience in laboratory diagnostics, she has worked across blood, stool, and urine testing platforms. At Diagnostic Solutions Laboratory, she plays a key role in test development and practitioner education, particularly in making complex biochemical concepts accessible and clinically applicable. Her background in sports performance nutrition and metabolism uniquely positions her to help practitioners understand and implement organic acids testing in clinical practice. Cass Nelson-Dooley, MS, studied medicinal plants in the rain forests of Panama, in 2003 as a Fulbright Scholar, and then launched a career in science and natural medicine. She researched the pharmacology of medicinal plants at the University of Georgia and AptoTec, Inc, and then joined the innovators at Metametrix Clinical Laboratory, then Genova Diagnostics. She has over 18 years of experience teaching clinicians about integrative and functional laboratory results. At Diagnostic Solutions Laboratory, she analyzes metabolomics and gut microbiome tests and develops educational tools. Ms. Nelson-Dooley owns Health First Consulting, LLC, a medical writing, patient education, and consulting firm that serves the integrative and functional medicine industry. Ms. Nelson-Dooley is the author of Heal Your Oral Microbiome and has published case studies, book chapters, and journal articles about natural medicine, nutrition, and laboratory testing. Order tests through Rupa Health, the BEST place to order functional medicine lab tests from 30+ labs - https://www.rupahealth.com/reference-guide

This week on The Huddle, we're resharing a discussion with current ADCES President, Veronica Brady, PhD, FNP-BC, BC-ADM, CDCES, FADCES. Veronica discussed the concept of unconscious bias, how it shows up in our everyday lives and in working as health care professionals, and how we can practice cultural humility to better serve the needs of people with and at risk for diabetes.  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Dr. Stephanie's Natural Supplements for Health & Wellness - formulated by Dr. Stephanie Redmond, PharmD, CDCES, BC-ADM. The products are crafted to simplify your wellness journey with all-in-one formulas that save you time & money – providing options for weight support, general health, and motherhood. Available for purchase at Amazon, Walmart, CVS, Walgreens, Kroger, and more.  Dr. Stephanie's Natural Supplements for Health & Wellness - formulated by Dr. Stephanie Redmond, PharmD, CDCES, BC-ADM. The products are crafted to simplify your wellness journey with all-in-one formulas that save you time & money – providing options for weight support, general health, and motherhood. Available for purchase at Amazon, Walmart, CVS, Walgreens, Kroger, and more.  https://byebyeweekend.com Key Information: Your Health, Simplified: Taking control of your health with natural solutions shouldn't be overwhelming. Dr. Stephanie's products are crafted to simplify your wellness journey with all-in-one formulas that save you time and money. We've done the research and combined the right ingredients in clinically effective doses to address your specific health needs. Clinically-Backed Doses: Our mission is to create supplements that prioritize efficacy over marketing gimmicks and proprietary doses. Every ingredient and dosage in Dr. Stephanie's products is supported by clinical studies, ensuring that each formula contains enough of the right ingredients to truly make a difference. Clean & High-Quality Ingredients: Your safety is our top priority. Dr. Stephanie's supplements are made in the USA in a cGMP facility and undergo third-party testing to guarantee accuracy, safety, and purity. We source only the highest-quality ingredients, so you can trust what's in every bottle. Learn more about your ad choices. Visit megaphone.fm/adchoices

This is a free preview of a paid episode. To hear more, visit rethinkingwellness.substack.comDietitian and diabetes educator Janice Dada joins us to discuss why there's so much stigma and blame on people with diabetes, the wellness-culture belief that people can “reverse diabetes” by restricting foods and taking a bunch of supplements, why people don't “give themselves diabetes” by eating too much sugar, the myth that people with diabetes can't eat sugar or carbs, her new book on intuitive eating for diabetes, and more. Behind the paywall, we get into the myths about diabetes and body size, the harms of trying to lose weight with diabetes, issues with the “prediabetes” label, the GLP-1 craze, and how to practice intuitive eating with diabetes.Paid subscribers can hear the full interview, and the first half is available to all listeners. To upgrade to paid, go to rethinkingwellness.substack.com.Janice Dada is a weight-inclusive registered dietitian with a private practice in Newport Beach, CA. She is a certified intuitive eating counselor, certified diabetes care and education specialist (CDCES), and certified eating disorders specialist (CEDS). She is passionate about simplifying and destigmatizing the nutrition- and weight-based discourse around diabetes. Intuitive Eating for Diabetes: The No Shame, No Blame, Non-Diet Approach to Managing Your Blood Sugar is her first book.If you like this conversation, subscribe to hear lots more like it!Support the podcast by becoming a paid subscriber, and unlock great perks like extended interviews, subscriber-only Q&As, full access to our archives, commenting privileges and subscriber threads where you can connect with other listeners, and more. Learn more and sign up at rethinkingwellness.substack.com.Christy's second book, The Wellness Trap, is available wherever books are sold! Order it here, or ask for it in your favorite local bookstore. If you're looking to make peace with food and break free from diet and wellness culture, come check out Christy's Intuitive Eating Fundamentals online course.